FLUVOXAMINE MALEATE | 			
Luvox | 
				
61718-82-9 | 			
Fevarin | 
				
Luvox CR | 			
Fluvoxamine (maleate) | 
				
DU23000 | 			
UNII-5LGN83G74V | 
				
54739-20-7 | 			
5LGN83G74V | 
				
C19H25F3N2O6 | 			
(Z)-but-2-enedioic acid;2-(E)-5-methoxy-1-4-(trifluoromethyl)phenylpentylideneaminooxyethanamine | 
				
DU-23000 | 			
Faverin | 
				
Floxyfral | 			
(E)-5-Methoxy-1-(4-(trifluoromethyl)phenyl)pentan-1-one O-(2-aminoethyl) oxime maleate | 
				
1-Pentanone, 5-methoxy-1-(4-(trifluoromethyl)phenyl)-, O-(2-aminoethyl)oxime, (E)-, (Z)-2-butenedioate (1:1) | 			
MK-264 | 
				
(E)-5-Methoxy-1-4-(trifluoromethyl)phenyl-1-pentanone O-(2-Aminoethyl)oxime Maleate | 			
(2Z)-but-2-enedioic acid; (E)-(2-aminoethoxy)({5-methoxy-1-4-(trifluoromethyl)phenylpentylidene})amine | 
				
SMR000466268 | 			
SMR000653482 | 
				
SR-01000075613 | 			
SME 3110 | 
				
Depromel | 			
MFCD00269809 | 
				
Fluvoxamine maleate USAN:USP | 			
Luvox (TN) | 
				
NSC 309469 | 			
Fluvoxamine maleate, solid | 
				
5-Methoxy-4-trifluoromethylvalerophenone (E)-O-2-aminoethyloxime monomaleate | 			
 Fluvoxamine maleate- Bio-X | 
				
5-Methoxy-4-(trifluoromethyl)valerophenone (E)-O-(2-aminoethyl)oxime, maleate (1:1) | 			
 CHEMBL1409 | 
				
SCHEMBL35225 | 			
MLS000028469 | 
				
MLS000758271 | 			
MLS001076285 | 
				
MLS001304717 | 			
MLS001401391 | 
				
CHEBI:5139 | 			
DTXSID3042558 | 
				
HY-B0103A | 			
Fluvoxamine maleate (JP17/USP) | 
				
HMS1571G11 | 			
HMS2098G11 | 
				
HMS3261D11 | 			
HMS3412A13 | 
				
HMS3676A13 | 			
HMS3715G11 | 
				
HMS3884K11 | 			
Pharmakon1600-01505604 | 
				
(2-aminoethoxy)({5-methoxy-1-4-(trifluoromethyl)phenylpentylidene})amine; but-2-enedioic acid | 			
SME-3110 | 
				
Tox21_500495 | 			
NSC309469 | 
				
NSC759602 | 			
s1336 | 
				
AKOS015961142 | 			
AC-9541 | 
				
CCG-213494 | 			
CS-1839 | 
				
NSC 759602 | 			
NSC-309469 | 
				
NSC-759602 | 			
NCGC00093897-01 | 
				
NCGC00093897-02 | 			
NCGC00261180-01 | 
				
(E)-5-Methoxy-1-(4-(trifluoromethyl)phenyl)-1-pentanone O-(2-aminoethyl)oxime (Z)-2-butenedioate (1:1) | 			
AS-11790 | 
				
BF164482 | 			
SMR000058449 | 
				
EU-0100495 | 			
F0858 | 
				
D00824 | 			
F 2802 | 
				
J90043 | 			
739F183 | 
				
A833394 | 			
SR-01000075613-1 | 
				
SR-01000075613-3 | 			
SR-01000075613-4 | 
				
SR-01000075613-6 | 			
Fluvoxamine maleate, British Pharmacopoeia (BP) Reference Standard | 
				
Fluvoxamine maleate, European Pharmacopoeia (EP) Reference Standard | 			
Fluvoxamine maleate, United States Pharmacopeia (USP) Reference Standard | 
				
5-Methoxy-1-(4-trifluoromethyl-phenyl)-pentan-1-one O-(2-amino-ethyl)-oxime maleate | 			
Fluvoxamine for system suitability, European Pharmacopoeia (EP) Reference Standard | 
				
Fluvoxamine maleate, 1.0 mg/mL in methanol ((as free base)), certified reference material | 			
Fluvoxamine Maleate, Pharmaceutical Secondary Standard; Certified Reference Material | 
				
(Z)-2-butenedioic acid; 2-(E)-5-methoxy-1-4-(trifluoromethyl)phenylpentylideneaminooxyethanamine | 			
(Z)-but-2-enedioic acid; 2-(E)-5-methoxy-1-4-(trifluoromethyl)phenylpentylideneaminooxyethanamine | 
				
1-Pentanone, 5-methoxy-1-4-(trifluoromethyl)phenyl-,O-(2-aminoethyl)oxime, (1E)-, (2Z)-2-butenedioate (1:1) | 			
2-({(1E)-5-methoxy-1-4-(trifluoromethyl)phenylpentylidene}amino)oxyethanamine (2Z)-but-2-enedioate |